A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease

Figure 4

KEGG pathways and GO analyses. (a) KEGG pathway enrichment; (b) biological press (BP); (c) cellular component (c); (d) molecular function (MF).

(a)

(b)

(c)

(d)